Jindong Li
Taizhou, 225300, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
ROS-Activatable "off-on" Fluorescent Prodrug Loaded Micelles for Targeted Therapy and in Situ Imaging of Breast Cancer Cells.
Journal: International journal of pharmaceutics: X
Published: April 25, 2026
Discovery of the First Highly Potent and Selective Peptide Inhibitor Targeting Microtubule-MAP7 Interaction via Structure-Based Design for Suppressing Colorectal Cancer Cell Proliferation.
Journal: Journal of medicinal chemistry
Published: January 21, 2026
Drynachromoside A from Drynaria fortunei attenuates oxidative stress and fibrosis of diabetic nephropathy via activating Nrf2 in vitro and in vivo.
Journal: Redox report : communications in free radical research
Published: November 20, 2025
Identification of a novel and high affinity MIF inhibitor via structure-based pharmacophore modelling, molecular docking, molecular dynamics simulations, and biological evaluation.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: June 16, 2025
Design, synthesis, and biological evaluation of JNK1 peptide inhibitors for alleviating insulin resistance in type 2 diabetes.
Journal: European journal of medicinal chemistry
Published: May 04, 2025
Discovery and biological evaluation of a novel and highly potent JAK2 inhibitor for the treatment of triple negative breast cancer.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: April 29, 2025
Design, synthesis, and biological evaluation of novel and highly potent peptides targeting syntenin.
Design, synthesis, and biological evaluation of novel and highly potent peptides targeting syntenin.
Journal: European journal of medicinal chemistry
Published: December 08, 2024
Structure-based design, synthesis and biological evaluation of a novel d-amino acid-containing peptide inhibitor by blocking the RAD51-BRCA2 interaction for the treatment of kidney cancer.
Journal: European journal of medicinal chemistry
Published: November 03, 2024
Discovery of novel PARP1/NRP1 dual-targeting inhibitors with strong antitumor potency.
Journal: Frontiers in pharmacology
Published: June 26, 2024
Discovery of potent heat shock protein 90 (Hsp90) inhibitors: structure-based virtual screening, molecular dynamics simulation, and biological evaluation.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: June 26, 2023
Highly potent dual-targeting angiotensin-converting enzyme 2 (ACE2) and Neuropilin-1 (NRP1) peptides: A promising broad-spectrum therapeutic strategy against SARS-CoV-2 infection.
Journal: European journal of medicinal chemistry
Published: May 22, 2023
Last Updated: 09/26/2026